These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4459126)

  • 1. A kinetic comparison of the physiological effects of clofibrate and clofenapate in the rat.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(2):80-8. PubMed ID: 4459126
    [No Abstract]   [Full Text] [Related]  

  • 2. Interlobular differences in the changes induced in rat liver by clofibrate and clofenapate.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(5):243-50. PubMed ID: 4461276
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of administration of clofibrate and clofenapate on the activities of glycerolphosphate dehydrogenase and catalase in rat kidney mitochondria.
    Krishnakantha TP; Kurup CK
    Indian J Biochem Biophys; 1973 Sep; 10(3):224-7. PubMed ID: 4792935
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of administration of clofibrate and clofenapate on oxidative phosphorylation by liver mitochondria in the rat.
    Krishnakantha TP; Mohan VP; Chhabra S; Kurup CK
    Indian J Biochem Biophys; 1975 Mar; 12(1):31-4. PubMed ID: 1205484
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
    Reddy JK
    Am J Pathol; 1974 Apr; 75(1):103-18. PubMed ID: 4825610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental and clinical evaluation of two "Atromid-S" analogues in relation to their differential modes of action.
    Stone MC; Thorp JM; Wain JS
    Adv Exp Med Biol; 1975; 63():151-65. PubMed ID: 173146
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of aldehyde dehydrogenase activity in rat liver by clofibrate feeding.
    Kramar R; Kremser K
    Enzyme; 1984; 31(1):17-20. PubMed ID: 6714196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in hepatic catalase and glycerol phosphate dehydrogenase activities on administration of clofibrate and clofenapate to the rat.
    Krishnakantha TP; Kurup CK
    Biochem J; 1972 Nov; 130(1):167-75. PubMed ID: 4655418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential increase of hepatic peroxisomal, mitochondrial and microsomal carnitine acyltransferases in clofibrate-fed rats.
    Markwell MA; Bieber LL; Tolbert NE
    Biochem Pharmacol; 1977 Sep; 26(18):1697-702. PubMed ID: 901588
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of administration of clofibrate and clofenapate on the content and distribution of ubiquinone in rat tissues.
    Krishnakantha TP; Kurup CK
    Indian J Biochem Biophys; 1974 Mar; 11(1):51-3. PubMed ID: 4435808
    [No Abstract]   [Full Text] [Related]  

  • 12. Further studies concerning the effects of clofibrate on respiration and oxidative phosphorylation of rat liver mitochondria.
    Mackerer CR; Haettinger JR
    Biochem Pharmacol; 1974 Dec; 23(23):3331-45. PubMed ID: 4374218
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of clofibrate on intracellular enzyme distribution in the rat liver].
    Panchenko LF; Popova SV; Pirozhkov SV; Antonenkov VD
    Tsitologiia; 1983 Nov; 25(11):1302-8. PubMed ID: 6659071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of cholesterol by rat liver mitochondria: effect of N-gamma-phenylpropyl-N-benzyloxy acetamide.
    Kritchevsky D; Tepper SA
    Arzneimittelforschung; 1970 Apr; 20(4):584-5. PubMed ID: 5467828
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of administration of clofibrate and clofenapate on kidney mitochondria of the rat.
    Krishnakantha TP; Kurup CK
    Biochem Pharmacol; 1973 May; 22(10):1245-7. PubMed ID: 4707606
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferators.
    Reddy JK; Moody DE; Azarnoff DL; Rao MS
    Proc Soc Exp Biol Med; 1977 Apr; 154(4):483-7. PubMed ID: 859854
    [No Abstract]   [Full Text] [Related]  

  • 17. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of liver and kidney catalase to alpha-p-chlorophenoxyisobutyrate (clofibrate) in C57B1/6J male mice of different ages.
    Baird MB; Zimmerman JA; Massie HR; Samis HV
    Gerontologia; 1974; 20(3):169-78. PubMed ID: 4461328
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of NAD-linked isocitrate dehydrogenase activity in rat liver by clofibrate feeding.
    Schön HJ; Kremser K; Prager C; Kramar R
    Biochem Pharmacol; 1991 Jun; 41(11):1773-5. PubMed ID: 2043166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential hypolipidemic agents. IX. Heterocyclic compouns related to methyl clofenapate.
    Gronowitz S; Svenson R; Bondesson G; Magnusson O; Stjernström NE
    Acta Pharm Suec; 1974 Jun; 11(3):211-24. PubMed ID: 4839733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.